Today: 8 February 2026
Subscribe
Browse Category

NYSE:ANF News 3 November 2025 - 13 January 2026

Abercrombie & Fitch stock dives after holiday update trims sales outlook — what investors watch next

Abercrombie & Fitch stock dives after holiday update trims sales outlook — what investors watch next

Abercrombie & Fitch shares fell about 20% Monday after the retailer cut its holiday-quarter outlook and trimmed its full-year sales growth forecast to at least 6%. The company cited higher planned spending and $90 million in tariff costs in its revised guidance. Fourth-quarter net sales are now projected to rise around 5%, below analyst estimates. Capital expenditure targets increased to $245 million.
12 January 2026
··
Abercrombie & Fitch (ANF) Stock on Dec. 24, 2025: Holiday-Shortened Rally, Analyst Targets, and the 2026 Outlook

Abercrombie & Fitch (ANF) Stock on Dec. 24, 2025: Holiday-Shortened Rally, Analyst Targets, and the 2026 Outlook

Abercrombie & Fitch shares nearly doubled from $65.61 on Nov. 24 to $126.78 at the Dec. 24, 2025 close, following a raised profit forecast and strong Hollister demand. The stock traded over 1 million shares in a holiday-shortened session, with market cap reaching $5.81 billion. ANF was among the highest dollar-volume apparel stocks, drawing traders’ attention amid record highs for U.S. indexes.
24 December 2025
··
Sudden Southern Park Mall Shutdown Shocks Community – Safety Scare, Unpaid Bills & Uncertain Future

Sudden Southern Park Mall Shutdown Shocks Community – Safety Scare, Unpaid Bills & Uncertain Future

Forecast: If Kohan Retail remains unwilling to invest in repairs or taxes, Southern Park Mall could face a protracted shutdown and accelerating tenant exodus. The holiday shopping season – normally the busiest period – will be all but lost if the mall stays closed, potentially pushing more retailers to exit. Over the longer term, experts say the best outcome may be for a new owner or new purpose to take over. “It’s best… to embrace what [Kohan is] doing and start to look at what the next generation of that land use could be,” Egelanian advises communitieswfmj.com. In other words,
3 November 2025
···

Stock Market Today

Thermo Fisher stock holds near $543 after Thursday slide as traders size up layoffs notice, data week ahead

Thermo Fisher stock holds near $543 after Thursday slide as traders size up layoffs notice, data week ahead

8 February 2026
cNew York, Feb 7, 2026, 17:29 EST — Market closed. Thermo Fisher Scientific (TMO.N) shares ended Friday, Feb. 6, at $542.83, steady on the day after a roughly 4% drop in the prior session. With U.S. markets shut on Saturday, traders head into Monday looking for signs the selloff has run its course. (Thermo Fisher Scientific) The stock has been jumpy because the company sits at the intersection of two messy lines: research spending that can disappear fast, and drugmakers’ demand for tools and services that tends to hold up. That split matters now because the next leg, up or
Disney stock ends week higher after Friday bounce — what to watch for DIS next week

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

7 February 2026
Disney shares closed up 3.6% at $108.70 Friday, recovering from earlier losses as U.S. stocks rallied and the Dow topped 50,000. Investors are watching Super Bowl streaming economics and Disney’s CEO transition, with Josh D’Amaro set to take over at the March 18 meeting. Disney reported quarterly revenue of $25.98 billion and adjusted EPS of $1.63, while segment operating income fell 9% to $4.6 billion.
Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

7 February 2026
Novo Nordisk Class B shares closed up 5.3% at 295.50 Danish crowns in Copenhagen after Hims & Hers said it would stop offering a compounded pill version of Wegovy following U.S. regulatory warnings. The move came after Novo called the Hims product “illegal mass compounding” and threatened legal action. Shares had fallen nearly 8% Thursday after Hims launched the pill. Trading resumes Monday.
Go toTop